SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : PolyMedix

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: tnsaf10/20/2010 11:37:08 AM
   of 77
 
PolyMedix to Present at the BioCentury NewsMakers in the Biotech Industry Conference

RADNOR, Pa.--(BUSINESS WIRE)-- PolyMedix, Inc. (OTC BB: PYMX), a biotechnology company focused on developing new therapeutic drugs to treat acute infectious diseases and cardiovascular disorders, announced today that Nicholas Landekic, the Company’s President & CEO, will present at the BioCentury NewsMakers in the Biotech Industry Conference on Friday, October 22, 2010 at 11:00 a.m. Eastern Time. The conference is being held at the Millennium Broadway Hotel in New York City.

The 17th Annual NewsMakers in the Biotech Industry Conference features companies with major product and earnings events that the conference organizers believe could be key to the next upswing. The objective of NewsMakers is to stimulate interest in a hand-picked group of public biotech companies with corporate and regulatory milestones into 2011 and beyond. NewsMakers is recognized as the industry’s key venue for companies to take their story to Wall Street each Fall. NewsMakers is an opportunity -- in a single day -- for the investment and pharma business development communities to assess the prospects for biotech stocks and to compare notes with key members of the institutional investment and analyst communities and pharma business development executives.

A live webcast of Mr. Landekic’s presentation will be available at corporate-ir.net or on the Company’s website at www.polymedix.com. A replay will be available on both sites for 90 days following the event.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext